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Abstract
Background: Overviews of reviews (overviews) compile data from multiple systematic reviews to provide a single
synthesis of relevant evidence for decision-making. Despite their increasing popularity, there is limited
methodological guidance available for researchers wishing to conduct overviews. The objective of this scoping
review is to identify and collate all published and unpublished documents containing guidance for conducting
overviews examining the efficacy, effectiveness, and/or safety of healthcare interventions. Our aims were to provide
a map of existing guidance documents; identify similarities, differences, and gaps in the guidance contained within
these documents; and identify common challenges involved in conducting overviews.
Methods: We conducted an iterative and extensive search to ensure breadth and comprehensiveness of coverage.
The search involved reference tracking, database and web searches (MEDLINE, EMBASE, DARE, Scopus, Cochrane
Methods Studies Database, Google Scholar), handsearching of websites and conference proceedings, and
contacting overview producers. Relevant guidance statements and challenges encountered were extracted, edited,
grouped, abstracted, and presented using a qualitative metasummary approach.
Results: We identified 52 guidance documents produced by 19 research groups. Relatively consistent guidance
was available for the first stages of the overview process (deciding when and why to conduct an overview,
specifying the scope, and searching for and including systematic reviews). In contrast, there was limited or
conflicting guidance for the latter stages of the overview process (quality assessment of systematic reviews and
their primary studies, collecting and analyzing data, and assessing quality of evidence), and many of the challenges
identified were also related to these stages. An additional, overarching challenge identified was that overviews
are limited by the methods, reporting, and coverage of their included systematic reviews.
Conclusions: This compilation of methodological guidance for conducting overviews of healthcare interventions
will facilitate the production of future overviews and can help authors address key challenges they are likely to
encounter. The results of this project have been used to identify areas where future methodological research is
required to generate empirical evidence for overview methods. Additionally, these results have been used to
update the chapter on overviews in the next edition of the Cochrane Handbook for Systematic Reviews of
Interventions.
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Background
Systematic reviews (SRs) combine the results of multiple
similar primary studies to answer a specific clinical ques-
tion [1]. With the exponential increase in the number of
published SRs [2], overviews of reviews (overviews) have
emerged as a logical solution to help manage this informa-
tion overload. The purpose of overviews is to integrate
information from multiple related SRs to provide a com-
prehensive synthesis of all SR evidence related to a specific
clinical question [3]. They are designed to be accessible,
user-friendly documents that are typically broader in
scope than any individual SR. Overviews are often con-
ducted to address questions related to the efficacy, effect-
iveness, and/or safety of healthcare interventions—for
example, examining multiple interventions for the preven-
tion or treatment of a specific health condition [3]. Table 1
describes the key characteristics of overviews.
Given their objective to synthesize extensive data in a
user-friendly format, overviews have been gaining mo-
mentum as a valuable knowledge synthesis product to
facilitate the uptake and application of knowledge by
decision-makers. Thus, the number of published over-
views has been steadily increasing in recent years [4–6].
This increase is at least partially due to the pioneering
efforts of The Cochrane Collaboration, an international
organization widely recognized as producing high-quality
SRs of health evidence [7]. In 2004, the Comparing
Multiple Interventions Methods Group (originally called
the Umbrella Reviews Methods Group) was established to
develop general guidance for conducting overviews [8].
This preliminary guidance was first published as a chapter
in the Cochrane Handbook for Systematic Reviews of
Interventions (Cochrane Handbook) in 2008 [3], and the
first overview was published in the Cochrane Database of
Systematic Reviews (CDSR) in 2009 [9]. Today, Cochrane
authors can publish overviews in the CDSR with a label
that allows readers to distinguish them from standard SRs.
Other research groups and organizations around the
world have also adopted this research design as a valuable
knowledge synthesis product [10, 11].
Overview methods evolved from SR methods for
which there are well-established standards of conduct to
ensure rigor, validity, and reliability of results [12]. Over-
views therefore aim to use explicit, reproducible, and
systematic methods to search for, identify, and extract
outcome data from SRs. However, since the unit of
searching, inclusion, and data extraction is the SR, over-
view authors often encounter unique methodological
challenges for which there are no obvious solutions or
clear guidance. As a result, current practice when con-
ducting overviews is driven largely by personal experi-
ence and trial and error, and published overviews show
considerable variation in their methods and reporting
[4–6]. In recent years, a number of overview authors have
recognized the methodological challenges inherent in con-
ducting overviews and expressed a need for comprehen-
sive, up-to-date guidance for overviews [4, 5, 13].
The purpose of this scoping review was to identify and
summarize all documents containing methodological
guidance for conducting overviews examining the efficacy,
effectiveness, and/or safety of healthcare interventions.
The aims were as follows: (1) locate, access, compile, and
create a map of documents that provide explicit methodo-
logical guidance for conducting overviews; (2) identify and
describe areas where guidance for conducting overviews is
clear and consistent, as well as areas where guidance is
conflicting or missing; and (3) document common chal-
lenges involved in conducting overviews and determine
whether existing guidance can help researchers overcome
these challenges. We then used the results of this scoping
review to update the chapter on overview methods
appearing in the Cochrane Handbook.
Methods
This scoping review adhered to the methods established
by Arksey and O’Malley [14] and expanded upon by
Levac et al. [15].
Eligibility criteria
To be included in the scoping review, documents had to
meet one of two criteria: (1) provide explicit guidance
for conducting overviews of healthcare interventions,
defined as any guidance related to either the context or
the process of conducting an overview or (2) describe an
author team’s experience conducting one or more
overviews of healthcare interventions. When selecting
documents for inclusion, we used the definition of
overviews provided in Table 1. We included guidance
that applied to overviews examining the efficacy, effect-
iveness, and/or safety of healthcare interventions and
excluded guidance that applied to other types of over-
views (e.g., diagnostic test accuracy, prognostic, and
qualitative overviews). We included documents pro-
duced in any language, year, or format.
Table 1 Key characteristics of overviews of reviews
1) Overviews should contain a clearly formulated objective designed to
answer a specific clinical research question, typically about a healthcare
intervention.
2) Overviews should intend to search for and include only systematic
reviews (with or without meta-analyses).
3) Overviews should use explicit and reproducible methods to identify
multiple systematic reviews that meet their inclusion criteria and to
assess the methodological quality of these systematic reviews.
4) Overviews should intend to collect, analyze, and present the
descriptive characteristics of their included systematic reviews (and their
primary studies) and the quantitative outcome data contained within
the systematic reviews.
Modified from Becker and Oxman and Hartling et al. [3, 4]
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Search methods for identification of documents
Our scoping review aimed to identify and include a wide
range of document types, including unpublished docu-
ments such as internal documents, training manuals,
and conference proceedings. We therefore conducted an
iterative and extensive search to ensure breadth and
comprehensiveness of coverage [14–17]. The search was
conducted between January and March 2014 and in-
volved reference tracking, database and web searches,
handsearching of websites and conference proceedings,
and contacting producers of overviews.
Our iterative reference tracking (“snowballing”) search
[16, 17] was conducted by a research librarian (RF). The
reference tracking search used a total of 30 target articles
about overviews that were identified by the study authors
prior to the start of the search and as the search
progressed. For each target article, we searched for “citing”
references using Google Scholar, “cited” references using
Scopus and reference lists, and “similar articles” using
PubMed. Database and web searches were conducted to
supplement and enhance our reference tracking search
(RF). We first updated the database searches reported in
Hartling et al. [4]. This involved searching MEDLINE (via
Ovid), EMBASE (via Ovid), DARE (via Cochrane Library),
and Scopus, for articles published between January 2010
and December 2013. We then augmented this search with
two additional databases (MEDLINE via Web of Science,
and Cochrane Methods Studies Database via Ovid) and
one additional web search engine (Google Scholar). Rele-
vant articles identified by the database and web searches
were fed back into the reference tracking search and used
as target articles to help locate additional relevant articles.
A number of additional sources were searched in an
attempt to locate all unpublished and internal guidance
documents (MP, RF). We handsearched the websites of 26
organizations that we knew had published at least one
overview, and the conference proceedings (2000–2013) of
three conferences: the International Cochrane Colloquium,
Health Technology Assessment International, and the
Canadian Agency for Drugs and Technologies in Health
Symposium. Additionally, we contacted overview producers
to ask if they had followed any specific guidance when
conducting their overview(s): this involved contacting 20
Managing Editors of Cochrane Review Groups and Fields
who oversaw the preparation of a combined 64 overviews
published in the CDSR and Evidence-Based Child Health:
A Cochrane Review Journal, and 110 authors who published
a combined 148 overviews in journals other than the CDSR
(lists of overviews obtained from [4] and [5]). We had
satisfactory response rates (57% for authors of conference
proceedings, 96% for Managing Editors of Cochrane
Review Groups and Fields, and 55% for overview authors).
We updated select components of the search in
November 2015. To ensure we continued to capture
relevant documents published after our search dates, we
used article alerts from MEDLINE (via Web of Science)
and Google Scholar to monitor new articles between
January 2014 and November 2015. Additionally, we
searched conference proceedings for 2014 and 2015 and
contacted an additional five Managing Editors of
Cochrane Review Groups who oversaw the preparation of
five overviews published in the CDSR in 2014 and 2015.
Finally, we handsearched the reference lists of the 52
guidance documents included in this scoping review.
Due to the variability in terminology used to refer to
overviews [4], we searched for and included terms such
as “overview,” “overview of reviews,” “overview of sys-
tematic reviews,” “umbrella review,” “systematic review
of systematic reviews,” and “metareview”. See Additional
file 1 for complete search strategies.
Selection of documents
All titles and abstracts were independently screened by
one reviewer (MP) and one research assistant. We kept
those documents that were not overviews but that met
the broad definition of “being about overviews” or
“discussing some aspect of overviews.” We then retrieved
the full text of all potentially relevant titles and abstracts.
Full-text articles were assessed for inclusion by two
independent reviewers (MP, LH) using the previously
described eligibility criteria, with discrepancies resolved
through discussion.
Data extraction and analysis
Relevant text contained within each included document
was extracted and analyzed using a qualitative metasum-
mary approach, which is an iterative, quantitatively
oriented method of data analysis that involves aggregat-
ing textual data to identify and expose patterns of
findings across groups of related documents [18, 19].
This involved extracting, editing, grouping, abstracting,
and presenting findings (this work was completed using
Microsoft Word and Excel). All data collection and
analysis was conducted by one reviewer (MP) and
checked for accuracy by a second reviewer (LH), with
disagreements resolved through discussion. The qualita-
tive metasummary process is described below.
First, we clearly specified the text eligible and not
eligible for extraction using the criteria presented in
Additional file 2 [18]. For documents that provided
explicit guidance for conducting overviews of healthcare
interventions, we extracted text that provided guidance
on how to conduct any part of an overview and text that
described challenges involved when conducting over-
views. For documents that described an author team’s
experience conducting one or more overviews of
healthcare interventions, we extracted only text that
described challenges author teams encountered. We
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then separated guidance statements and challenges
from all other text in the documents, and edited the
guidance and challenges to ensure that they were pre-
sented in a way that was accessible to readers while
preserving their underlying content and meaning [18].
Guidance statements and challenges were then
separated from each other and grouped, abstracted,
and presented in parallel.
For both guidance statements and challenges, we used
a two-stage approach to group similar findings together.
First, we grouped all documents produced by the same
research group to avoid giving extra weight to state-
ments that were included in multiple documents pro-
duced by the same research group [18]. Within each of
these groupings, we further edited the findings to elim-
inate redundancies and duplicate text while leaving the
meaning of the statements unchanged. Second, we
grouped statements across research groups by stage of
the overview process to ensure that all statements re-
lated to the same stage of the overview process appeared
in the same place [18]. The stages of the overview
process included the following: deciding when and why
to conduct an overview, specifying the scope, searching
for and including SRs, quality assessment of SRs and
their primary studies, collecting and analyzing data,
grading quality of evidence, and drawing conclusions.
These stages were identified iteratively: they were se-
lected in advance using the stages presented in the
Cochrane Handbook [12] and modified as needed to ac-
commodate the specific guidance and challenges identified.
We then abstracted findings to summarize the content
of each group of topically related guidance statements
and challenges [18, 19]. For each stage of the overview
process, we reworked our lists of guidance statements
and challenges until we developed a new list of ab-
stracted statements that captured the overall meaning of
the original statements. This was done by eliminating
redundancies, refining statements to ensure they were
inclusive of the ideas presented by each research group,
preserving ambiguity and contradictions, and ensuring
clarity and accessibility.
Lastly, we provided a narrative summary of the ab-
stracted guidance statements followed by a narrative
summary of the abstracted challenges. For guidance
statements only, we also calculated frequency and
intensity effect sizes. These were used to extract more
meaning from the narrative summaries by numerically
describing the magnitude of the abstracted findings
[18, 19]. Frequency effect sizes were calculated by divid-
ing the number of research groups contributing guid-
ance on a topic area by the total number of research
groups. Intensity effect sizes were calculated by dividing
the number of topic areas addressed by each research
group by the total number of topic areas.
Results
Results of the search
The literature search retrieved 2418 unique references.
One hundred seventy-six references were identified as
potentially eligible, and the full-text articles were assessed
for inclusion. Of these, 124 documents were excluded (list
available upon request). Fifty-two documents produced by
19 research groups were included; these documents are
listed in Additional file 3 and are labeled “A1,” “A2,”…,
“A52” in the text below. Figure 1 contains a flow diagram
of documents through the review process. As anticipated,
published articles that could be located through database
searching comprised a minority (29%) of included docu-
ments; the majority (71%) were unpublished documents
identified through other searching methods.
Summary of included guidance documents
Table 2 summarizes the characteristics of the included
guidance documents and presents abbreviations for
research groups that will be used throughout the re-
mainder of the results.
Of the 52 included documents, 41 provided explicit
methodological guidance for conducting overviews of
healthcare interventions (Additional file 3, references
A1–A41). These documents were produced between
2007 and 2015 by 12 research groups (range, 1–18 docu-
ments per group). The three most common types of
documents were oral presentations (37%), journal arti-
cles (24%), and internal documents (22%). Four research
groups (CHF, CMIMG, CPHG, EPOC) contributing 28
documents (68%) had primary affiliations associated with
The Cochrane Collaboration. Eleven documents de-
scribed an author team’s experience conducting one or
more overviews of healthcare interventions (Additional
file 3, references A42–A52). These documents (5 post-
ers, 4 journal articles, 2 oral presentations) were pro-
duced between 2004 and 2015 by nine research groups
(range, 1–2 documents per group). Six research groups
(CCRG, CHF, CM, CS, DDC, EPOC) contributing 8 doc-
uments (73%) had primary affiliations associated with
The Cochrane Collaboration. We first summarize the
existing guidance for conducting overviews, with fre-
quency and intensity effect sizes. We then summarize
the challenges identified.
Guidance for conducting overviews
The guidance contained within the 41 documents that
provided explicit methodological guidance fell into two
broad categories: guidance related to the context for
conducting overviews and guidance related to the
process of conducting overviews. These categories could
be further subdivided into 15 topic areas. The existing
methods guidance for each topic area is summarized
below; italicized terms are defined in Table 3.
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Guidance related to the context for conducting overviews
Choosing between conducting an overview and a SR
Two groups provided guidance on this topic (CMIMG,
EPPI). The CMIMG stated that authors should conduct
an overview only when they intend to search for and ex-
tract data from SRs as opposed to primary studies. Au-
thors should conduct a SR when they intend to search for
or extract data from primary studies, conduct a network
meta-analysis, or rank order interventions (A16). When
choosing between both study designs, the scope of the
research question should be taken into account (A12). See
reference A23 for additional guidance on choosing be-
tween both study designs (CMIMG). EPPI-Centre stated
that authors may consider conducting an overview when a
broad research question co-occurs with a short time frame
and limited resources (A30).
What types of questions about healthcare interven-
tions can be answered using the overview format?
One group (CMIMG) provided guidance on this topic,
though six additional groups (CHF: A2; DukeU: A29;
Fig. 1 Flow diagram of documents through the scoping review
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Table 2 Characteristics of included guidance documents (52 documents produced by 19 research groups)
Documents that contain explicit methodological guidance for conducting
overviews (41 documents produced by 12 research groups)
Documents that describe an author team’s experience conducting
one or more published overviews (11 documents produced by 9
research groups)
Research group Number of documents
(Additional file 3 references)
Years documents
were produced
Document formats Number of documents




Cochrane Child Health Field (CHF) 11a
(A1–A11)
2010–2015 6 oral presentationsa, 2 internal
documents, 2 posters, 1 journal article
2
(A42, A43)
2011–2013 1 journal article, 1
poster
Cochrane Comparing Multiple
Interventions Methods Group (CMIMG)
18a
(A1, A6, A7, A12–A26)
2008–2015 10 oral presentationsa, 5 internal
documents, 1 journal article,
1 book chapter, 1 website
– – –
Cochrane Consumers and
Communication Review Group (CCRG)
– – – 1
(A44)
2009 1 journal article
Cochrane Effective Practice and
Organization of Care Review Group (EPOC)
1
(A27)





Cochrane Musculoskeletal Review Group (CM) – – – 1
(A47)
2010 1 poster
Cochrane Public Health Group (CPHG) 1
(A28)
2014 1 journal article – – –
Cochrane Stroke Group (CS) – – – 1
(A48)
2015 1 oral presentation
Duke University (DukeU) 1
(A29)
2012 1 journal article – – –
Dutch Cochrane Centre (DCC) – – – 1
(A49)
2009 1 poster
Evidence for Policy and Practice
Information and Co-ordinating Centre (EPPI)
2
(A30, A31)
2015 1 journal article, 1 oral presentation – – –
Joanna Briggs Institute Umbrella
Reviews Methodology Group (JBI)
4
(A32–A35)
2007–2015 2 internal documents, 1 journal article,
1 book chapter
– – –
Ludwig Boltzmann Institute for Health
Technology Assessment (LBI)
– – – 1
(A50)
2015 1 journal article




2013 1 book chapter – – –
Pontifical Xavierian University (PXU) – – – 1
(A51)
2011 1 poster
Trinity College Dublin (TCD) 1
(A37)
2011 1 journal article – – –
University of Birmingham (UBirm) 1
(A38)
2012 1 journal article – – –
University of Dundee (UDun) – – – 1
(A52)
2004 1 journal article
Western Journal of Nursing Research (WJNR) 1
(A39)
2014 1 editorial – – –
Witten/Herdecke University (WHU) 2
(A40, A41)
2014 2 journal articles – – –
aThree documents are counted twice because they were produced by authors affiliated with both of these groups (Additional file 3, references A1, A6, and A7). For these three documents, guidance presented by DC,












JBI: A34; NOKC: A36; TCD: A37; UBirm: A38) refer-
enced this guidance in their own documents. The
CMIMG stated that overviews can summarize evidence
from multiple SRs about “different interventions for the
same condition; the same intervention for different
conditions; the same intervention for the same condition
where different outcomes are addressed in different SRs;
or adverse effects of interventions” (A16).
Questions to consider before deciding to conduct an
overview Six groups (CHF, CMIMG, EPPI, JBI, TCD,
WJNR) stated that the overview format must be suitable
for the proposed research question. Questions to con-
sider include the following: is the topic clinically relevant
(CHF: A8); is the field too new or changing too rapidly
to preclude the utility of an overview (EPPI: A30); are
there enough relevant SRs on major interventions and/
or disorders of interest (e.g., are SRs up-to-date and
clinically and methodologically homogeneous) (CHF: A8;
CMIMG: A16; WJNR: A39); have important organizational
factors been considered (e.g., author team, time frame, and
funding) (CHF: A8; CMIMG: A14; JBI: A34; TCD: A37);
and does it make methodological sense to include all SRs in
the same overview (e.g., has the transitivity assumption
been met) (CHF: A3; CMIMG: A24)? The CHF states that
proper planning is important and that authors should “be-
ware of the common misperception that overviews are easy
and straightforward” (A3).
Author team composition and roles Four groups
(CHF, CMIMG, JBI, WJNR) stated that a complete
multidisciplinary author team is needed that ideally
includes a project coordinator (CHF: A4), clinician or
content expert (CHF: A9), researcher with methodo-
logical expertise (CHF: A9; CMIMG: A20; JBI: A34;
WJNR: A39), statistician (as needed) (CHF: A9;
CMIMG: A20), and information specialist (as needed)
(CHF: A9). Additional members may also be required,
and roles should correspond to each member’s area of
expertise (CHF: A9). See reference A9 for additional de-
tail on team member roles (CHF).
Target audience of the overview Eight groups (CHF,
CMIMG, DukeU, EPOC, EPPI, TCD, WHU, WJNR)
stated that the target audience for overviews is health-
care decision-makers including clinicians (CHF: A10;
CMIMG: A16; EPOC: A27; TCD: A37; WHU: A41;
WJNR: A39), researchers (DukeU: A29; EPOC: A27;
WJNR: A39), informed patients/consumers (CHF: A10;
CMIMG: A16; WHU: A41), and policy-makers/commis-
sioning agents (CHF: A10; CMIMG: A16; EPOC: A27;
EPPI: A30; WHU: A41; WJNR: A39).
Guidance related to the process for conducting overviews
Specifying the scope Ten groups provided guidance on
this topic (CHF, CMIMG, CPHG, DukeU, EPOC, EPPI,
JBI, NOKC, TCD, WJNR). They stated that authors
should clearly specify and describe the clinical character-
istics (e.g., populations, interventions, comparators, and
outcomes) and study design information (e.g., SRs) of
interest for the overview (CHF: A8; CMIMG: A16;
CPHG: A28; EPOC: A27; JBI: A34; NOKC: A36; TCD:
A37; WJNR: A39). Reference A9 contains additional
detail about specifying outcomes of interest (CHF).
Additionally, authors may wish to restrict their scope
based on clinical or methodological characteristics
(CHF: A6; CMIMG: A16; DukeU: A29; EPOC: A27;
EPPI: A30; JBI: A33; NOKC: A36; TCD: A37).
Searching for SRs Eleven groups provided guidance on
this topic (CHF, CMIMG, CPHG, DukeU, EPOC, EPPI,
JBI, NOKC, TCD, WHU, WJNR). They stated that
authors should search the CDSR to locate Cochrane SRs
(CHF: A8; CMIMG: A16; EPPI: A30; JBI: A34; TCD:
Table 3 Definitions
Indirect comparison: “A comparison of two interventions via one or
more common comparators. For example, the combination of
intervention effects from AC and intervention effects from BC studies
may (in some situations) be used to learn about the intervention
effect AB.” (http://methods.cochrane.org/cmi/node/61)
Network meta-analysis: “An analysis that syntheses information over a
network of comparisons to assess the comparative effects of more
than two alternative interventions for the same condition. A network
meta-analysis synthesizes direct and indirect evidence over the entire
network, so that estimates of intervention effect are based on all
available evidence for that comparisons. This evidence may be direct
evidence, indirect evidence or mixed evidence. Typical outputs of a
network meta-analysis are a) relative intervention effects for all com-
parisons; and b) a ranking of the interventions.” (http://methods.co-
chrane.org/cmi/node/61)
Non-Cochrane systematic reviews: Systematic reviews published
outside of the Cochrane Database of Systematic Reviews.
Overlapping systematic reviews: Two or more systematic reviews
examining the same intervention for the same disorder. Overlapping
systematic reviews will often contain one or more of the same
primary studies, which may lead to including the same study’s
outcome data in an overview two or more times.
Quality of evidence: The confidence we have in the outcome effect
estimates, often assessed using the Grading of Recommendations
Assessment, Development and Evaluation (GRADE) tool.
Transitivity assumption: “The situation in which an intervention effect
measured using an indirect comparison is valid and equivalent to the
intervention effect measured using a direct comparison. Specifically,
the transitivity assumption states that (the benefit of A over B) is
equal to (the benefit of A over C) plus (the benefit of C over B).
Equivalently, this may be written as (the benefit of A over C) minus
(the benefit of B over C). In practice, transitivity requires similarity;
that is that the sets of studies used to obtain the indirect comparison
are sufficiently similar in characteristics that moderate the
intervention effect. Transitivity can be thought of as a network meta-
analysis extension of the idea of homogeneity in a standard meta-
analysis.” (http://methods.cochrane.org/cmi/node/61)
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A37). To locate non-Cochrane SRs, authors should
search additional databases (e.g., MEDLINE, EMBASE)
and SR registries (e.g., Epistemonikos) (CHF: A8;
CMIMG: A26; CPHG: A28; DukeU: A29; EPOC: A27;
EPPI: A30; JBI: A34; TCD: A37; WJNR: A39) and
contact experts or conduct handsearching of sources
relevant to the topic (JBI: A34; TCD: A37). Overview
authors may choose to use SR-specific search terms and/
or validated SR search filters (CHF: A8; DukeU: A29;
EPOC: A27; JBI: A34; TCD: A37). They may also restrict
their search by date, language, and/or publication status,
if appropriate (CPHG: A28; DukeU: A29; EPOC: A27; JBI:
A34; TCD: A37). Conflicting guidance was provided
regarding whether or not overview authors should search
for and include primary studies that are not contained
within any included SR (CHF: A2; CMIMG: A16; CPHG:
A28; DukeU: A29; EPPI: A30; NOKC: A36; WHU: A41).
Different ways of searching for primary studies were
described, for example, see reference A41 (WHU).
Selecting SRs for inclusion Six groups (CHF, CMIMG,
DukeU, EPOC, NOKC, TCD) indicated that authors
should select SRs for inclusion using pre-defined inclu-
sion criteria. The scopes of the SRs and overview may
sometimes differ (DukeU: A29; NOKC: A36); in these
cases, authors must assess the primary studies contained
within each SR for inclusion, and they should only in-
clude the subset of primary studies that meet the over-
view’s inclusion criteria (CHF: A8; CMIMG: A16). Two
groups (EPOC: A27; TCD: A37) recommended that doc-
uments be assessed for inclusion by two independent
reviewers with consensus.
Should an overview include non-Cochrane SRs? Nine
groups provided guidance on this topic (CHF, CMIMG,
DukeU, EPOC, EPPI, JBI, NOKC, TCD, WHU). Two
groups affiliated with The Cochrane Collaboration (CHF:
A8; CMIMG: A16) stated that authors of Cochrane over-
views should include only Cochrane SRs, if possible, but
they also stated that including non-Cochrane SRs has
both advantages (e.g., greater topic coverage) and disad-
vantages (e.g., increases complexity of the overview).
The groups provided conflicting guidance regarding
whether or not overview authors should use SR quality
as an inclusion criterion for non-Cochrane SRs (and if
so, what procedure to follow and which tool to use)
(CHF: A8; DukeU: A29; EPOC: A27; EPPI: A30; JBI:
A34; NOKC: A36; TCD: A37; WHU: A40). There was
uncertainty and conflicting guidance on the methods
that should be used to manage overlapping SRs in over-
views (e.g., should authors include only one SR per topic
area, or should they include all relevant SRs regardless
of overlap?) (CHF: A8; CMIMG: A26; DukeU: A29;
EPPI: A30; TCD: A37; WHU: A41). See reference A40
(WHU) for ways to assess and report overlap in over-
views, and references A8 (CHF) and A29 (DukeU) for
ways to potentially manage overlap in overviews.
Assessing quality of included SRs All 12 groups stated
that quality assessment of SRs is important and should
be done. Conflicting guidance was provided regarding
the tool that should be used, though A MeaSurement
Tool to Assess systematic Reviews (AMSTAR) [20] was
mentioned most often, by seven research groups (CHF:
A8; CMIMG: A16; DukeU: A29; EPOC: A27; JBI: A33;
TCD: A37; WJNR: A39). Six groups recommended dual
independent quality assessments with consensus
(CMIMG: A16; DukeU: A29; EPOC: A27; JBI: A34;
NOKC: A36; TCD: A37). No other guidance was pro-
vided describing the specific methods that should be
used to assess SR quality (e.g., whether and how to
modify the quality assessment tool for use in overviews).
Collecting and presenting data on descriptive charac-
teristics of included SRs (and their primary studies)
Six groups (CHF, CMIMG, EPOC, JBI, TCD, WJNR) pro-
vided guidance on this topic. They stated that authors
should extract information about the objectives, inclusion
criteria, and methods of each included SR (CHF: A8;
CMIMG: A16; EPOC: A27; JBI: A33; TCD: A37; WJNR:
A39). Authors should also extract information about the
primary studies included in each SR (CHF: A8; EPOC:
A27; JBI: A33; TCD: A37; WJNR: A39).
Collecting and presenting data on quality of primary
studies contained within included SRs Seven groups
provided conflicting guidance regarding how overview
authors should collect and present data on primary
study quality; methods proposed included extracting and
reporting the quality assessments conducted within each
SR or referring back to each primary study to conduct
quality assessments (CHF: A8; CMIMG: A16; DukeU:
A29; EPPI: A30; JBI: A34; NOKC: A36; WJNR: A39).
Four groups explicitly recommended the former method
over the latter, if possible (CHF: A8; CMIMG: A16; JBI:
A34; NOKC: A36). No guidance was provided regarding
the logistical concerns likely to be encountered (e.g., use
of different quality assessment tools in different SRs).
Collecting, analyzing, and presenting outcome data
Seven groups provided guidance on this topic and de-
scribed quantitative and narrative methods of presenting
data (CHF, CMIMG, DukeU, EPOC, EPPI, JBI, UBirm).
Three groups (CHF: A8; DukeU: A29; UBirm: A38) stated
that outcome data could be extracted from SRs and ana-
lyzed or presented in a different way than the analyses
contained within the SRs (e.g., using meta-analysis or
other complex methods). Two groups (CMIMG: A16; JBI:
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A33) stated that outcome data could simply be presented
in the overview as they were presented in SRs. Two
groups (EPOC: A27; EPPI: A30) acknowledged both ap-
proaches without recommending one over the other. Re-
search groups advised that the most appropriate method
of data analysis may depend upon the overview’s research
question and the amount of clinical, methodological, and/
or statistical heterogeneity in the SRs (CHF: A9; CMIMG:
A12; EPPI: A30). Three groups recommended dual inde-
pendent data extraction with consensus (EPOC: A27; JBI:
A33; UBirm: A38). Research groups provided limited
guidance regarding the logistical concerns likely to be en-
countered when analyzing outcome data. For example,
there is uncertainty regarding how to analyze data from
overlapping SRs (though at a minimum, authors should
acknowledge the overlap and potential for bias) (CHF: A9;
CMIMG: A26; EPPI: A30; JBI: A33; also see WHU: A40).
Assessing quality of evidence of outcome data Six
groups stated that it is important to assess the quality of
evidence, for example, using the Grading of Recommen-
dations Assessment, Development and Evaluation
(GRADE) tool (CHF: A8; CMIMG: A16; EPPI: A30; JBI:
A34; NOKC: A36; TCD: A37) [21]. However, only two
groups provided guidance regarding how to assess qual-
ity of outcome data in overviews; they stated that au-
thors could either extract quality assessments from
included SRs or conduct quality assessments themselves
at the overview level (CHF: A8; CMIMG: A16). CMIMG
recommended that two reviewers independently assess
quality of evidence with a process for consensus (A16).
No other guidance was provided regarding the logistical
concerns likely to be encountered when conducting
quality assessments (e.g., what if not all SRs assessed
quality of evidence?).
Interpreting outcome data and drawing conclusions
Three groups (CMIMG, EPPI, WHU) provided guidance
on this topic. They stated that authors must ensure that
the conclusions they make are warranted based on the
quality of the primary studies and SRs and the methods
used to analyze data (CMIMG: A16; EPPI: A30). Au-
thors should avoid making informal indirect comparisons
across different interventions because the transitivity as-
sumption will likely be problematic (CMIMG: A24). Au-
thors should also state whether more research is likely
to change the results of the overview (based on quality
of evidence, if assessed) (WHU: A41).
Frequency and intensity effect sizes
The research groups that contributed the most guidance
to this scoping review, as measured using intensity effect
sizes (Table 4), were as follows: CMIMG (15/15 topics),
CHF (13/15 topics), and EPPI and JBI (11/15 topics
each). The topic areas that the most research groups dis-
cussed, as measured using frequency effect sizes, were as
follows: “assessing quality of SRs” (12/12 groups),
“searching for SRs” (11/12 groups), and “specifying the
scope” (10/12 groups). Topics that the least number of
research groups discussed were as follows: “choosing be-
tween conducting an overview and a SR” (2/12 groups),
“interpreting outcome data and drawing conclusions” (3/
12 groups), and “author team composition and roles” (4/
12 groups each).
Challenges identified when conducting overviews
All 19 research groups contributing explicit guidance
and/or author experiences identified at least one chal-
lenge involved when conducting overviews of healthcare
interventions. These challenges are summarized in
Table 5. Nine research groups also described limitations
inherent to the overview format itself (CHF, CMIMG,
CPHG, DukeU, EPOC, EPPI, JBI, WHU, WJNR). Specif-
ically, they stated that overviews can be complex and re-
source intensive (CHF: A43; EPOC: A46; EPPI: A30;
WHU: A40); susceptible to bias (CMIMG: A17; CPHG:
A28; DukeU: A29; EPPI: A30; JBI: A34; WHU: A40); and
dependent on (and limited by) the scope, inclusion cri-
teria, methods, reporting, and coverage of their included
SRs (CHF: A9; CPHG: A28; DukeU: A29; EPOC: A45;
EPPI: A30; JBI: A34; WHU: A41; WJNR: A39). Few of
the challenges identified when conducting overviews
were adequately addressed by the methodological guid-
ance previously summarized.
Discussion
This scoping review found relatively consistent and com-
prehensive guidance for the first stages of the overview
process, from choosing to conduct an overview through
to selecting SRs for inclusion. Guidance for the latter
stages was often conflicting and/or missing, and a num-
ber of outstanding challenges were identified. These lat-
ter stages included the following: deciding whether to
include SRs published outside of the CDSR, assessing
quality of SRs and their primary studies, collecting and
analyzing data, and assessing quality of evidence of out-
come data.
The shift from consistent to conflicting and/or missing
guidance that occurs after the inclusion stage may be
due to several factors. First, this is the point at which
guidance for overviews takes on an additional level of
complexity. Within an overview, there are two levels for
assessing and reporting SR/study characteristics, quality/
risk of bias, and outcome data (i.e., for both the SRs and
their included primary studies). Existing methodological
guidance does not yet adequately address how these
stages of the overview process should occur relative to
these two levels of information. Second, SRs are
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syntheses of pre-existing data, and we found that over-
views are limited by the methods and reporting of their
included SRs. Data may be missing, inadequately reported,
or reported differently across included SRs, and it is
currently unclear whether overview authors should rely
solely on the SRs as they were conducted and presented,
or whether and to what extent authors should refer back
to the primary studies for additional information. Lastly,
including SRs published outside of the CDSR can increase
the complexity of the latter stages of the overview process
due to greater variation in the methods and reporting of
non-Cochrane SRs [22, 23] and the potential for topic
overlap across multiple similar SRs [24]. Limited guidance
was available regarding the specific methods authors can
use to address and manage these issues in overviews.
To circumvent some of the challenges authors are
likely to encounter during the latter stages of the over-
view process, authors should first ensure that the over-
view format is appropriate for their question of interest.
The CMIMG in particular provided comprehensive
guidance regarding the context for conducting an over-
view (i.e., when and why to conduct an overview); how-
ever, much of this guidance is currently in the form of
internal documents and conference proceedings that may
be difficult for authors to access. Authors should also pre-
pare a detailed protocol for their overview. Often overview
authors describe their scope and inclusion criteria but
provide less detail about methods to be used for quality
assessments and data extraction and analysis. As well as
reducing bias and promoting rigor and transparency of
methods [11, 25], a protocol would allow overview authors
to become familiar with the challenges they are likely to
encounter and develop a priori decision rules to appropri-
ately address those challenges. The guidance and chal-
lenges described in this paper will be useful for authors to
consider when developing their protocols.
As is common when using a qualitative metasummary
approach [18], an important insight emerged when we
analyzed our data across topic areas, namely, that over-
views are often conducted for one of two main purposes.
Table 4 Map of methodological guidance for conducting overviews
Topic area CHF CMIMG CPHG DukeU EPOC EPPI JBI NOKC TCD UBirm WHU WJNR Frequency
effect size
Guidance related to the context for conducting overviews (i.e., when and why should you conduct an overview?)
Choosing between conducting an
overview and a SR
✓ ✓ 2/12
What types of questions about
healthcare interventions can be
answered using the overview format?
✓ ✓ ✓ ✓ ✓ ✓ ✓ 7/12
Questions to consider before deciding
to conduct an overview
✓ ✓ ✓ ✓ ✓ ✓ 6/12
Author team composition and roles ✓ ✓ ✓ ✓ 4/12
Target audience of the overview ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 8/12
Guidance related to the process of conducting overviews (i.e., how do you conduct an overview?)
Specifying the scope ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 10/12
Searching for SRs ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 11/12
Selecting SRs for inclusion ✓ ✓ ✓ ✓ ✓ ✓ 6/12
Should an overview include
non-Cochrane SRs?
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 9/12
Assessing quality of included SRs ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 12/12
Collecting and presenting data on
descriptive characteristics of included
SRs (and their primary studies)
✓ ✓ ✓ ✓ ✓ ✓ 6/12
Collecting and presenting data on
quality of primary studies contained
within included SRs
✓ ✓ ✓ ✓ ✓ ✓ ✓ 7/12
Collecting, analyzing, and presenting
outcome data
✓ ✓ ✓ ✓ ✓ ✓ ✓ 7/12
Assessing quality of evidence of
outcome data
✓ ✓ ✓ ✓ ✓ ✓ 6/12
Interpreting outcome data and
drawing conclusions
✓ ✓ ✓ 3/12
Intensity effect size 13/15 15/15 3/15 9/15 8/15 11/15 11/15 8/15 10/15 3/15 5/15 8/15
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Table 5 Common challenges involved in conducting overviews
Topic area Number of groups contributing
challenges (/19)
Summary of challenges identified
Challenges related to the context for conducting overviews (i.e., when and why should you conduct an overview?)
Choosing between conducting an overview
and a SR
1 (CMIMG) Network meta-analyses are very difficult to conduct in
overviews and should likely not be conducted within
overviews. It may be difficult to determine whether it is
more appropriate to conduct an overview, or a systematic
review with or without network meta-analysis.
What types of questions about healthcare
interventions can be answered using the
overview format?
2 (CCRG, CM) Methods used to conduct overviews may vary
according to the type of question (e.g., scope, clinical
characteristics) being posed in the overview.
Questions to consider before deciding to
conduct an overview
5 (CHF, CMIMG, DCC, JBI, UDun) Should authors conduct an overview if there are not
enough relevant SRs (e.g., if SRs do not address all
important interventions)?
Author team composition and roles 2 (CHF, CMIMG) Overview authors often have limited time. What skills are
required for authors wishing to conduct overviews?
Target audience of the overview 0 No challenges identified.
Challenges related to the process of conducting overviews (i.e., how do you conduct an overview?)
Specifying the scope 4 (EPPI, LBI, UBirm, UDun) Defining the scope, and selecting and prioritizing
outcomes, can be difficult. The scope of the overview
may have almost complete overlap, or very limited
overlap, with the scope of the relevant SRs.
Searching for SRs 5 (CHF, CPHG, EPOC, LBI, UBirm) Search strategies can be complex. It is unclear whether
government reports that include both primary studies
and SRs should be included in an overview. It is unclear
whether and how overview authors should search for
primary studies that are not contained within any included SR.
Selecting SRs for inclusion 8 (CHF, CMIMG, DukeU, EPPI, JBI,
UBirm, UDun, WHU)
It is unclear whether lower-quality SRs or older SRs should
be included or excluded. Decisions surrounding inclusion
and exclusion can affect the efficiency, utility, and breadth
of the overview.
Should an overview include non-Cochrane SRs? 9 (CHF, CMIMG, CPHG, DukeU, EPOC,
EPPI, TCD, WHU, WJNR)
Including non-Cochrane SRs can be difficult and will increase
the complexity of the overview process. Non-Cochrane SRs
can be of low methodological quality and may be poorly
reported. Additionally, some Cochrane and non-Cochrane
SRs will have overlap in their clinical questions, inclusion
criteria, and/or included primary studies, and may have
discordant results and/or conclusions. Overlapping SRs
can be problematic, and there are potential challenges
involved in assessing the amount of overlap in included SRs.
Additionally, methods for choosing between overlapping SRs
have not yet been developed; for example, it is unclear
whether authors should include only one SR per topic area
(and if so, which one?), or if they should include all SRs
regardless of overlap (and if so, how will overlap
be managed?).
Authors including non-Cochrane SRs also have to clearly
define what counts as a SR.
Assessing quality of included SRs 9 (CCRG, CHF, CMIMG, CPHG, EPOC,
EPPI, PXU, UBirm, UDun)
Assessing quality of SRs can be difficult and time-consuming.
Many different tools could be used to assess SR quality, and
some tools designed to assess quality may also assess
reporting. There is also uncertainty surrounding how to
interpret and apply the results of quality assessments in the
context of overviews.
Collecting and presenting data on
descriptive characteristics of included
SRs (and their primary studies)
11 (CCRG, CHF, CM, CMIMG, DCC,
DukeU, EPOC, JBI, LBI, UDun, NOKC)
Data may be missing, inadequately reported, or reported
differently across included SRs, and it is unclear what to do
when reporting is incomplete (e.g., should the data be
extracted from primary studies?). Additionally, data extraction
errors in SRs could lead to errors in the overview.
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The first purpose is to present and describe the
complete body of SR evidence on a clearly defined topic
[26, 27]. The second purpose is to address a question
that differs from the question(s) in the underlying SRs
and that often relates to a subset of the questions in the
SRs (e.g., subpopulations, or subsets of interventions or
outcomes) [28, 29]. Distinguishing between these two
purposes, and recognizing that different methods may
be used for each, can help resolve some discrepancies
and challenges likely to be encountered during the latter
stages of the overview process. For example, if the pur-
pose is to answer a different question from those posed
in the SRs, authors may wish to re-extract and re-
analyze outcome data (e.g., using meta-analysis) from a
set of non-overlapping SRs. However, if the purpose is to
describe the complete body of SR evidence on a topic,
authors may find it more appropriate to include all rele-
vant SRs regardless of topic overlap and then present
these results as they appeared in the SRs. Empirical evi-
dence will be needed to determine whether these ap-
proaches affect the results or introduce bias at the
overview level.
Ultimately, methodological guidance is required for
those stages of the overview process where guidance is
conflicting and/or missing and where outstanding chal-
lenges remain. This future guidance should be based on
Table 5 Common challenges involved in conducting overviews (Continued)
Collecting and presenting data on quality
of primary studies contained within included
SRs
7 (CCRG, CHF, CM, DCC, EPOC,
EPPI, UDun)
Collecting and presenting quality of primary studies can be
difficult and time-intensive. Information about the quality of
primary studies included in SRs may be missing, inadequately
reported, or reported differently across included SRs. For
example, different SRs may use different tools to assess
quality of primary studies.
Collecting, analyzing, and presenting outcome
data
15 (CCRG, CHF, CM, CMIMG, DCC, DukeU,
EPOC, EPPI, JBI, LBI, NOKC, UBirm, UDun,
WJNR, WHU)
Collecting, analyzing and presenting outcome data can
be difficult, especially when the scope, methods, or results
of the included SRs are heterogeneous. Outcome data may
be missing, inadequately reported, or reported inconsistently
across included SRs, and it is unclear what to do in these
situations (e.g., should the data be extracted from primary
studies instead?). It is also unclear how best to summarize
and report outcome data that comes from overlapping
(and potentially discordant) SRs. It may not always be possible
or appropriate to conduct meta-analyses in overviews or
to directly compare results across different SRs. Similarly,
network meta-analyses are often not appropriate in overviews.
Additionally, overviews may not accurately capture
information about adverse effects or cost-effectiveness of
interventions, and data extraction errors in SRs could lead
to errors in the overview.
Assessing quality of evidence of outcome data 9 (CCRG, CHF, CM, CPHG, DCC, EPOC,
PXU, UDun, WHU)
It may not be possible to simply extract existing GRADE
assessments from SRs. However, it may be challenging to
conduct (or re-do) GRADE assessments at the overview level,
using data from SRs. For example: data needed to assess
quality of evidence in SRs may be missing, inadequately
reported, and/or reported differently across included SRs;
the “study quality” domain may be assessed differently
across similar SRs (e.g., different tools used, same tool used
but different assessments obtained, only summary
assessments reported); and the “consistency” and “precision”
domains may be affected if different methodological
decisions are made in similar SRs (e.g., pooling versus not
pooling data). Additionally, achieving consensus may be
difficult. The GRADE tool may need to be modified for use
in overviews.
Interpreting outcome data and drawing
conclusions
6 (CHF, CMIMG, DukeU, EPOC, LBI, WJNR) Interpreting outcome data and drawing conclusions
can be difficult. There is uncertainty surrounding how
to interpret outcome data in overviews. It can be
difficult to form a coherent judgment when multiple
different comparisons from multiple SRs are included in
the same overview, and/or when overlapping SRs report
discordant results. It can also be difficult to determine
implications for research. Additionally, there is concern
that the methods used to conduct overviews might
affect the conclusions reached.
CDSR Cochrane Database of Systematic Reviews, DARE Database of Abstracts of Reviews of Effectiveness, EMBASE Excerpta Medica dataBASE, GRADE Grading of
Recommendations Assessment, Development and Evaluation, PICO populations, interventions, comparators, and outcomes, SR systematic review
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empirical evidence generated from well-conducted studies
that evaluate methods for conducting overviews. While
outside of the scope of the present paper, we identified
several relevant methods studies (recently published, and
in progress) when conducting this scoping review. These
methods studies examined the following: implications of
including multiple SRs published on the same topic area
[24]; issues related to quality assessment of SRs [30–32];
different methods for presenting outcome data [33];
methods for assessing quality of evidence using GRADE
[34, 35]; and reporting conflicts of interest in overviews
[36]. One additional study (in progress) was identified that
will aim to summarize all empirical studies [37]. Develop-
ing future methodological guidance for overviews based
on the results of empirical studies will help ensure that
guidance is based on sound evidence as opposed to per-
sonal experience or trial and error.
The current scoping review aimed to identify and collate
all documents containing methodological guidance for
conducting overviews of healthcare interventions. Due to
the variety of publication formats for overview methods
guidance and the difficulty in locating and accessing these
documents, it is possible we may have missed relevant
guidance documents. To maximize retrieval, our search
utilized multiple complimentary methods in addition to
database searching. We had satisfactory response rates
(ranging from 55 to 96%) when locating and obtaining the
full text of unpublished documents, and we were able to
translate and extract data from all relevant non-English
documents identified. We then used a rigorous process for
identifying, extracting, and analyzing guidance statements
and challenges from these documents. Importantly, we
were interested in method guidance and challenges for
overviews examining the efficacy, effectiveness, and/or
safety of healthcare interventions and have excluded
guidance and challenges specific to overviews that may
address broader or different clinical questions. Guidance
for conducting these other types of overviews is also needed
but is outside the scope of the current project. It is
important to note that the guidance and challenges sum-
marized here was written by research groups with different
organizational processes that likely produce overviews with
differing purposes, scopes, target audiences, and/or re-
source requirements. Researchers should identify the
purpose, scope, target audience, and resource requirements
of their overview at the outset and determine how well the
guidance and challenges presented here apply to their
specific situation. Lastly, the guidance included in this
scoping review came from documents that explicitly
intended to provide methods guidance to readers: the
methods presented here do not come from the actual
methods used in published overviews. However, discussions
with overview authors [13] and critical appraisal of pub-
lished overviews [4, 5, 38, 39] indicates that the guidance
and challenges in this scoping review are congruent with
overview authors’ experiences.
Conclusions
This scoping review provides a systematic summary of
existing methodological guidance for conducting over-
views examining the efficacy, effectiveness, and/or safety
of healthcare interventions. It highlights the stages of
the overview process where guidance is consistent, con-
flicting, or missing, and it also provides a summary of
the challenges involved in conducting overviews. This
scoping review will serve as a useful resource for authors
wishing to conduct overviews, as well as researchers
wishing to conduct empirical research on overview
methods. It is also a necessary first step to developing a
cohesive methods guidance document that addresses
relevant issues and areas of uncertainty when conduct-
ing overviews of healthcare interventions. Accordingly,
the results of this scoping review were used to update
the chapter on overview methods in the Cochrane
Handbook. There has been a dramatic rise in the pro-
duction of SRs and overviews in recent years. These syn-
theses are an important vehicle to increase the uptake
and application of knowledge by clinical and policy
decision-makers, and they can help address crucial
health issues and ultimately improve health outcomes in
diverse populations. Investing in strengthening the
methods guidance for conducting overviews can help
ensure a rigorous and valid evidence base for knowledge
translation and dissemination.
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